Leena Bruckner-Tuderman  Molecular Therapy 

Slides:



Advertisements
Similar presentations
Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.
Advertisements

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Copyright © 2016 McGraw-Hill Education. All rights reserved.
Volume 20, Issue 2, (February 2012)
209. Use of Helicobacter pyroli Neutrophil Activating Protein (NAP) as an Immune- Modulatory Agent To Enhance the Efficacy of Oncolytic Adenovirus Therapy.
Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers  Melinda Mata, Stephen.
Genome-editing Technologies for Gene and Cell Therapy
627. Non-Invasive, Multimodal Imaging of Microvesicles with Metabolically Biotinylated, Membrane-Bound Gaussia Luciferase    Molecular Therapy  Volume.
Volume 24, Issue 11, Pages (November 2016)
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
Hydrodynamic Gene Delivery: Its Principles and Applications
Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)
Evolving Gene Therapy in Primary Immunodeficiency
Volume 20, Issue 6, Pages (June 2012)
Leena Bruckner-Tuderman, Cristina Has 
343. Benchtop DNA Synthesizer: Oligo-Templated Polymerization (OTP)
Escaping the Valley of Death
Progress in Molecular Genetics of Heritable Skin Diseases: The Paradigms of Epidermolysis Bullosa and Pseudoxanthoma Elasticum  Jouni Uitto, Leena Pulkkinen,
Volume 26, Issue 2, Pages (February 2018)
Volume 25, Issue 1, Pages 5-7 (January 2017)
A Theranostic “SMART” Aptamer for Targeted Therapy of Prostate Cancer
Rodger C. Haggitt, MD Gastrointestinal Endoscopy
Jan Hoinka, Phuong Dao, Teresa M Przytycka 
The Other Face of Chimeric Antigen Receptors
Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015  Jouni Uitto, Leena Bruckner-Tuderman,
724. Blood-Derived Endothelial Progenitor Cells Can Be Isolated With a Novel Method of Diluted Whole Blood Incubation with AMD3100-Induced Mobilization.
Thermal Memory in Self-Assembled Collagen Fibril Networks
Genome-editing Technologies for Gene and Cell Therapy
Valder R Arruda, Patricia Favaro, Jonathan D Finn  Molecular Therapy 
Premal Lulla, Carlos A. Ramos  Molecular Therapy 
Molecular Therapy  Volume 20, (May 2012) DOI: /S (16)
Molecular Therapy  Volume 7, Issue 5, (May 2003) DOI: /S (16)
Leena Bruckner-Tuderman, John A. McGrath, E
Adenovirus Virion Stability and the Viral Genome: Size Matters
847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach    Molecular.
Designer Lipids Advance Systemic siRNA Delivery
Volume 20, Issue 6, Pages (June 2012)
133. Survival with Normal Neurological Development of the Juvenile Lethal Urea Cycle Defect Arginase Deficient Mouse with AAV Gene Therapy    Molecular.
Erratum The American Journal of Human Genetics
660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy  Geeta Shroff  Molecular Therapy 
68. Site Specific Intra-Placental Gene Transfer Corrects Fetal Growth Restriction in a Novel Mouse Model of Placental Insufficiency (PI)    Molecular.
521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies    Molecular Therapy  Volume 22, Pages.
405. Hindlimb and Forelimb Strength Assessment in a Canine Model of X-Linked Myotubular Myopathy Following AAV-Mediated Gene Replacement    Molecular.
Live and Let Die: A New Suicide Gene Therapy Moves to the Clinic
674. Molecular, Biochemical and Biomechanical Analysis of Articular Cartilage Repaired with Genetically Modified Chondrocytes Expressing Insulin-Like.
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Disruption of ERBB2IP Is not Associated with Dystrophic Epidermolysis Bullosa in Both Father and Son Carrying a Balanced 5;13 Translocation  Margarita.
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular.
Molecular Heterogeneity of Epidermolysis Bullosa Simplex: Contribution of EXPH5 Mutations  Manuela Pigors, Agnes Schwieger-Briel, Juna Leppert, Dimitra.
521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS  Brad E. Hoffman  Molecular.
Gregory G. Ginsberg, MD  Gastrointestinal Endoscopy 
Medical Treatment of Overactive Bladder: In Response
773. Detection of RNA Interference (RNAi) Mediated mRNA Cleavage in Fresh Injected Tumor Tissue from Patients in a Phase I Trial of pbi-shRNA™ Lipoplex.
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Volume 17, Issue 9, Pages (September 2009)
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
History of Oncolytic Viruses: Genesis to Genetic Engineering
Fibrosis in Fontan physiology
86. A Highly Compact Epitope-Based Marker Suicide Gene for Safer and Easier Adoptive T-Cell Gene Therapy    Molecular Therapy  Volume 20, Pages S35-S36.
Kazim H Narsinh, Jordan Plews, Joseph C Wu  Molecular Therapy 
Novel Keratin 14 Mutations in Patients with Severe Recessive Epidermolysis Bullosa Simplex  Cristina Has, Yow-Ren Chang, Andreas Volz, Doris Hoeping,
Epidermolysis Bullosa: The Expanding Mutation Database
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
Childhood epidermolysis bullosa acquisita with autoantibodies against all 3 structural domains of type VII collagen  Takaya Fukumoto, MD, Toshiki Umekawa,
Volume 23, Issue 1, Pages vii-ix (January 2015)
624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results    Molecular.
Presentation transcript:

Can Type VII Collagen Injections Cure Dystrophic Epidermolysis Bullosa?  Leena Bruckner-Tuderman  Molecular Therapy  Volume 17, Issue 1, Pages 6-7 (January 2009) DOI: 10.1038/mt.2008.262 Copyright © 2009 The American Society of Gene Therapy Terms and Conditions

Figure 1 Schematic representation of the polymerization of anchoring fibrils. The type VII procollagen monomer consists of three α1(VII) polypeptide chains folded into a triple helix. Two monomers form an antiparallel dimer, from which the NC-2 propeptides are removed proteolytically. Finally, the mature dimers laterally aggregate into anchoring fibrils. (Courtesy of Johannes Kern, University Medical Center, Freiburg, Germany.) Molecular Therapy 2009 17, 6-7DOI: (10.1038/mt.2008.262) Copyright © 2009 The American Society of Gene Therapy Terms and Conditions